• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: A.I.D.D LONGFORD ALINITY LACTATE DEHYDROGENASE2; NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

A.I.D.D LONGFORD ALINITY LACTATE DEHYDROGENASE2; NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE Back to Search Results
Catalog Number 04T99-30
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/20/2022
Event Type  malfunction  
Event Description
The customer observed falsely elevated alinity c ldh results for one patient.The following data was provided (reference range: 125-220 u/l): ac01723.(b)(6) 2022, (b)(6) ldh2 535 u/l (high), repeated on another instrument (data not available) (b)(6) 2022, (b)(6) ldh2 476 u/l (high), repeated on another instrument (data not available) two additional sids were provided ((b)(6)), however, no values were provided.No impact to patient management was reported.
 
Manufacturer Narrative
Patient identifier: (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The ticket search by lot indicates that the reagent lot performs as expected for this product.Return testing was not performed as returns were not available.Device history record review was performed on lot 39506ud00, which did not show any potential non-conformances, deviations, or non-conformances.Trending review did not identify any trends for the complaint issue.Labelling review concludes that the issue is adequately addressed.In house accuracy testing was performed using retained reagent file samples of lot 39506ud00.The testing results met acceptance criteria and the product is performing as expected.Based on all reviewed data, we conclude that there is no product deficiency with the alinity lactate dehydrogenase2 reagent identified in this complaint.Corrected information found in section d4.Catalogue number changed to 04t99-30.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY LACTATE DEHYDROGENASE2
Type of Device
NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE
Manufacturer (Section D)
A.I.D.D LONGFORD
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
A.I.D.D LONGFORD
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key15528642
MDR Text Key302366244
Report Number3005094123-2022-00210
Device Sequence Number1
Product Code CFJ
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/25/2023
Device Catalogue Number04T99-30
Device Lot Number39506UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/19/2022
Initial Date FDA Received10/03/2022
Supplement Dates Manufacturer Received11/21/2022
Supplement Dates FDA Received11/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/12/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY C PROCESSING MODU, 03R67-01, (B)(6); ALNTY C PROCESSING MODU, 03R67-01, (B)(6)
-
-